This result corresponded with the clinical study in patients with breast cancer, where CD44, Oct3/4, and Notch-4, but not ALDH1A1, were significantly expressed in the tumor tissues compared with the normal epithelial tissues of patients with breast cancer [46]. This evidence concerns the gene CD44 and breast cancer.